The mechanistic hypothesis: Semaglutide activates GLP-1R, appetite suppression, glycemic control Cagrilintide activates amylin receptors, appetite suppression via the area postrema, slowing of gastric evacuation Two independent mechanisms of appetite suppression a supra-additive effect In Phase 1b and Phase 2 trials the combination showed a stronger effect than either component alone : Semaglutide alone: 14.9 % (STEP-1) Cagrilintide alone (Phase 2): 10.8 % CagriSema combination (Phase 2): 15.6 % CagriSema Phase 3 (REDEFINE 1): 25.3 % CagriSema thus becomes the largest body-weight signal reported in the published incretin literature to date , stronger than Tirzepatide (22.5 % in SURMOUNT-1) and comparable to Retatrutide
Retatrutide lowers LDL , likely due to its unique glucagon receptor activation
By incorporating Semaglutide into your weight management plan, youre taking a proactive step toward achieving your goals
Although it remains in the blood system for several hours, nerve activity and other hormones can affect GLP-1 production and levels
3-hydroxy-4-trimethylammoniobutanoate 66
A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome